Market Cap N/A
Revenue (ttm) 6.71M
Net Income (ttm) 2.25M
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin 33.58%
Debt to Equity Ratio N/A
Volume 395,500
Avg Vol N/A
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K N/A
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

Anbio Biotechnology provides in vitro diagnostics (IVD) products in the European Union, the Asia Pacific, North America, South America, Africa, and internationally. It offers SARS-CoV-2 antigen rapid and SARS-CoV-2/influenza A/B antigen rapid tests; and lateral flow immunoassay, fluorescence immunoassay, loop-mediated isothermal amplification, chemiluminescence immunoassay, and reverse-transcription polymerase chain reaction products. It serves over-the-counter, point-of-care testing, and labora...

Industry: Medical Instruments & Supplies
Sector: Healthcare
Phone: 49 16 0962 47281
Address:
Wilhelm Gutbrod Str 21B, Frankfurt am Main, Germany